Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia

NCT04453384 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

416

Enrollment

OTHER

Sponsor class

Conditions

SARS Virus

Interventions

DRUG: XAV-19
DRUG: Placebo

Sponsor

Nantes University Hospital

Collaborators

[object Object]
[object Object]